ArticleClinical and experimental nephrology2026
Erythropoiesis-stimulating agent hyporesponsiveness and malignancy development in patients with non-dialysis chronic kidney disease: a prospective cohort study.
Nobuhiro Hashimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.